Exagen Inc. (XGN) Earnings History
Annual and quarterly earnings data from 2012 to 2025
Loading earnings history...
XGN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
XGN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 58.3% | -21.1% | -30.0% |
| 2024 | 59.5% | -24.5% | -27.2% |
| 2023 | 56.1% | -43.5% | -45.1% |
| 2022 | 46.9% | -101.1% | -104.0% |
| 2021 | 57.4% | -49.8% | -55.6% |
Download Data
Export XGN earnings history in CSV or JSON format
Free sign-in required to download data
Exagen Inc. (XGN) Earnings Overview
As of May 8, 2026, Exagen Inc. (XGN) reported trailing twelve-month net income of -$20M, reflecting -12.0% year-over-year growth. The company earned $-0.93 per diluted share over the past four quarters, with a net profit margin of -30.0%.
Looking at the long-term picture, XGN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$7M in fiscal 2012.
Exagen Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CDNA (-$8M net income, -5.6% margin), NTRA (-$208M net income, -9.0% margin), VCYT ($88M net income, 12.8% margin), XGN has room to improve margins relative to the peer group. Compare XGN vs CDNA →
XGN Earnings vs Peers
Earnings metrics vs comparable public companies
XGN Historical Earnings Data (2012–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$20M | -32.0% | -$14M | $-0.93 | -30.0% | -21.1% |
| 2024 | -$15M | +36.2% | -$14M | $-0.83 | -27.2% | -24.5% |
| 2023 | -$24M | +50.0% | -$23M | $-1.34 | -45.1% | -43.5% |
| 2022 | -$47M | -76.5% | -$46M | $-2.77 | -104.0% | -101.1% |
| 2021 | -$27M | -60.9% | -$24M | $-1.68 | -55.6% | -49.8% |
| 2020 | -$17M | -38.6% | -$15M | $-1.32 | -39.8% | -36.2% |
| 2019 | -$12M | -50.2% | -$9M | $-0.96 | -29.8% | -23.0% |
| 2018 | -$8M | +68.7% | -$5M | $-127.16 | -24.7% | -15.0% |
| 2017 | -$26M | -33.6% | -$8M | $-406.81 | -95.6% | -29.2% |
| 2015 | -$19M | -28.0% | -$10M | $-305.48 | -106.9% | -57.9% |
See XGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXGN — Frequently Asked Questions
Quick answers to the most common questions about buying XGN stock.
Is XGN growing earnings?
XGN EPS fell to $-0.93, with earnings declining -12.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-20M.
What are XGN's profit margins?
Exagen Inc. net margin is -30.0%, with operating margin at -21.1%. Below-average margins reflect competitive or cost pressures.
How consistent are XGN's earnings?
XGN earnings data spans 2012-2025. The declining earnings trend is -12.0% YoY. Historical data enables comparison across business cycles.